SYRE

Spyre Therapeutics Inc

May 19 • 10:39AM ET

65.56

-4.53 -6.46 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: LKFT ROIV APLS VERA KYMR

| Held by: VTI IWM XBI VXF IBB IWO VTWO SCHA IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	12.54%	Shs Outstand	78.84M	Perf Week	-12.64%
Market Cap	5.69B	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-2.50%	Shs Float	75.95M	Perf Month	-10.68%
Enterprise Value	5.11B	PEG	-	EPS next Q	-0.73	Inst Own	85.85%	Short Float	16.09%	Perf Quarter	79.11%
Income	-168.74M	P/S	-	EPS this Y	-47.69%	Inst Trans	22.33%	Short Ratio	10.98	Perf Half Y	178.96%
Sales	0.00M	P/B	10.04	EPS next Y	-7.78%	ROA	-25.30%	Short Interest	12.22M	Perf YTD	100.11%
Book/sh	6.53	P/C	7.68	EPS next 5Y	-22.35%	ROE	-29.26%	52W High	78.80 -16.81%	Perf Year	340.56%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 370.60%	Perf 3Y	1696.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.37% 6.01%	Perf 5Y	-63.53%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.46	Perf 10Y	-64.37%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	44.70	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	-9.17%	Beta	3.10	Target Price	95.20
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	10.06%	Rel Volume	1.50	Prev Close	70.08
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	89.54%	Avg Volume	1.11M	Price	65.56
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	364,416	Change	-6.46%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)